Page 18 - TD-2-1
P. 18

Tumor Discovery                                                              Cancer progression in PCOS




            Table 1. Prevalence of reproductive cancer in polycystic ovary syndrome patients
             Type of study  Location     Total     Cancer type     Number of     Adjusted HR/RR/SIR/  References
                                      participants  (reproductive)  cancer patients  OR (95% CI value)
            Cohort         Denmark      12,070     Endometrium        16            3.9 (2.2 – 6.3)    [69]
                                                   Ovarian            10            1.8 (0.8 – 3.2)
                                                   Breast             59            1.1 (0.8 – 1.4)
                                                   Cervix uteri       14            0.8 (0.5 – 1.4)
            Registry-based   Taiwan      3,566     Ovarian             2          0.997 (0.214 – 4.636)  [70]
            cohort                                 Breast             14          1.976 (1.035 – 3.722)
                                                   Uterine            15          8.420 (1.615 – 43.888)
            Meta-analysis  USA           919       Endometrium         5           2.79 (1.31 – 5.95)  [61]
                           Japan                   Ovarian             3           1.41 (0.93 – 2.15)
                           Australia
                           Europe                  Breast              3           0.95 (0.64 – 1.39)
            Meta-analysis  United      938 (cancer   Endometrium      938           2.9 (1.5 – 5.5)    [71]
                           Kingdom     patients)
            Retrospective   USA          2,560     Uterine corpus      5           1.28 (0.49 – 3.35)  [79]
            cohort                                 Ovarian             2           0.42 (0.10 – 1.75)
                                                   Breast             23           0.81 (0.53 – 1.25)
            Case-control   Australia     1,399     Endometrium        156          3.64 (1.76 – 7.52)  [72]
            Cross-sectional  United      128       Endometrium        11            1.0 (0.4 – 2.7)    [67]
                           Kingdom
            Cohort         USA          116,671    Breast             2267          0.8 (0.6 – 1.0)    [83]
            HR: Hazard ratio; OR: Odds ratio; RR: Relative risk; SIR: Standardized incidence ratio

            primary infertility (RR = 0.42; 95% CI = 0.10 – 1.75) .   meta-analysis, no increased risk was seen in women with
                                                        [79]
            In-depth research is required to ascertain if PCOS is related   PCOS (OR = 1.0; 95% CI = 0.6 – 1.4) . When compared
                                                                                             [61]
            to ovarian cancer.                                 to women who had not been treated for infertility, women
                                                               with ovulatory problems had a considerably lower risk of
            3.1.3. Breast cancer                               breast cancer (RR = 0.8; 95% CI = 0.6 – 1.0) . In a study
                                                                                                  [83]
            Data from several organizations have shown that breast   conducted by Brinton et al., the patients with PCOS did
                                               [80]
            cancer is the most common cancer in women . According   not appear to have an increased risk of breast cancer
            to statistics from 2018, 627,000 women died from breast   (RR = 0.81; 95% CI = 0.53 – 1.25) .
                                                                                          [79]
            cancer, accounting for 15% of all cancer fatalities in women.
            Although breast cancer rates are greater in more developed   3.2. Risk and underlying factors of developing non-
            areas, they are rising practically in every area of the world .   reproductive cancer in polycystic ovary syndrome
                                                        [61]
            There is a theory that the dysregulated genes observed   PCOS patients have direct and indirect risks of developing
            in PCOS patients and the genes linked to breast cancer   cancers in their later life. If left untreated, the risk
            overlap. Three such potential genes, discovered by Xu et al.,   of developing atypical endometrial hyperplasia and
            include alpha polypeptide, platelet-derived growth factor   carcinoma  is  high  due  to  irregular  menstruation  with
            receptor, and hydroxysteroid (17-beta) dehydrogenase .  protracted  exposure  to  unobstructed  estrogen .  These
                                                      [81]
                                                                                                     [84]
              However, there have been studies done that did not find   risks are significantly higher among women with obesity or
            any connection between PCOS patients and a higher risk   who are overweight. Only a few studies on the association
            of breast cancer . With 59 breast cancer cases observed   of PCOS with non-reproductive cancers are available
                         [82]
            and 56 expected, a recent Danish registry-based study has   (Table 2). A registry-based cohort study by Gottschau et al.
            found no association between PCOS and breast cancer   reported elevated risk of colon, kidney, and brain cancers,
            risk, with an SIR of 1.1 (95% CI = 0.8 – 1.4) . Similarly,   with SIR of 2.1, 3.9, and 2.2, respectively (95% CI = 1.1 – 3.8,
                                                [69]
            a retrospective and cohort study in Taiwan has also   1.4 – 8.4, and 1.3 – 3.5, respectively), among PCOS patients
            found no association between PCOS and breast cancer   but no significant risk of other types of cancers, such as
            risk (HR  =  1.6, 95% CI = 0.9 – 2.8) . According to a   lung cancer, melanoma, and other types of skin cancers .
                                                                                                           [69]
                                           [70]
            Volume 2 Issue 1 (2023)                         5                           https://doi.org/10.36922/td.328
   13   14   15   16   17   18   19   20   21   22   23